Can a 30-Minute chat ease cancer Patients' radiation fears?
NCT ID NCT04507568
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 30-minute education session with a radiation therapist, before standard radiotherapy, can reduce anxiety and improve quality of life for breast cancer patients. About 109 participants will be randomly assigned to either the extra session or standard care. Researchers will measure anxiety, self-confidence, and satisfaction through questionnaires.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- person-centered education session with a radiation therapist
- What this could lead to
- If it works, this could show that a short education session helps breast cancer patients feel less anxious and more in control during radiotherapy.
- What could go wrong
- This is a small, single-center study, so results may not apply to all patients. The intervention is brief and may not significantly change anxiety levels.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
109 people
The number who actually took part.
- Started
-
Aug 2020
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients 18 years or older * Diagnosis of non-metastatic breast cancer * Intended to receive radiation therapy to the breast/chest-wall and regional lymph nodes * Ability to communicate in English without assistance of another person * Ability to provide informed consent Exclusion Criteria: * Commenced any radiation therapy-specific procedures (e.g. education, CT-simulation, etc.) * Received a previous course of radiation therapy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2C1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?